Real Chemistry Acquires Avant Healthcare
February 6, 2024
Real Chemistry has acquired Avant Healthcare, a Carmel, Indiana-based medical communications firm, to expand its medical education, medical affairs and HCP communications capabilities. The acquisition, which closed Feb. 1, 2024 for undisclosed terms, more than doubles Real Chemistry’s medical team and enhances its scientific, data-driven medical communications offering for life sciences clients.
- Buyers
- Real Chemistry
- Targets
- Avant Healthcare
- Industry
- Healthcare Services
- Location
- Indiana, United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Real Chemistry Acquires Spring & Bond
October 15, 2025
Marketing & Advertising
Real Chemistry has acquired Spring & Bond, a New York–based digital media agency focused on omnichannel, data-driven media for the healthcare sector. The deal strengthens Real Chemistry's media and omnichannel capabilities; Spring & Bond's founder Elizabeth Beringer will continue to lead the team reporting to Kevin Johnson.
-
Real Chemistry Acquires Greater Than One
July 22, 2025
Marketing & Advertising
Real Chemistry has acquired Greater Than One, an award-winning healthcare-first media, technology and omnichannel strategy agency. The deal brings Greater Than One's proprietary media planning and engagement tools into Real Chemistry's AI-driven healthcare marketing platform to expand capability and performance for pharma and biotech clients; terms were not disclosed.
-
Real Chemistry Acquires TI Health and Integrates It into Swoop
March 1, 2023
Data & Analytics
Real Chemistry has acquired TI Health, a data-driven HCP engagement and predictive analytics company, and will integrate TI Health into Swoop to create a unified HCP and DTC system of engagement for healthcare marketers. TI Health, previously a portfolio company of Capital Dynamics, Star Mountain Capital, and Halyard Capital, will bring its Affiniti platform and HCP targeting capabilities to Swoop’s privacy-safe patient audiences to enable coordinated omnichannel campaigns.
-
Real Chemistry Acquires conversationHEALTH
April 5, 2022
Healthcare Services
Real Chemistry, a San Francisco-based health innovation company, has acquired conversationHEALTH, a HIPAA-compliant conversational AI SaaS platform for the health care and life sciences industry. The acquisition expands Real Chemistry's Data and Artificial Intelligence Solutions capabilities by adding conversational AI, medically-trained NLU and intelligent agents for scientific communications, medical affairs, clinical trials and commercial operations.
-
X-Chem Acquires IntelliSyn and AviSyn to Expand Drug Discovery Services
January 26, 2021
Biotechnology
X-Chem, a portfolio company of GHO Capital, has acquired Montreal-based IntelliSyn and its US-based sister company AviSyn to extend its drug discovery offering into medicinal chemistry, custom synthesis and scale-up process chemistry. The deal integrates downstream hit validation and lead optimisation capabilities into X-Chem’s DNA-Encoded Library (DEL) platform, enabling a streamlined screen-to-lead service for pharma and biotech clients; financial terms were not disclosed.
-
Amplity Health Acquires RealHealthData
January 1, 2019
Data & Analytics
Amplity Health has acquired RealHealthData and integrated its real-world data analytics capabilities into a new practice called Amplity Insights. The acquisition adds unstructured clinical and provider encounter data and analytic tooling to Amplity’s healthcare commercialization services to enhance client insights and decision-making.
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.